Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
México
79
Veracruz
79
Historia
51
poesía
48
Mexico
41
literatura
41
Literatura
38
reseña
37
educación superior
32
Xalapa
30
ensayo
30
higher education
28
Reseña
25
música
25
siglo XX
25
Argentina
24
COVID-19
23
China
23
traducción
23
Bibliometrics
22
Educación
22
Educación superior
21
Mujeres
21
Violencia
21
memoria
21
Bibliometría
20
España
20
Estado
18
Porfiriato
18
educación
18
-
23961“…VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1348836442160205.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23962por Elyamany, Ghaleb, Alzahrani, Ali Matar, Aljuboury, Muna, mogadem, Najlah, Rehan, Nagham, Alsuhaibani, Omar, Alabdulaaly, Abdulaziz, Al-Mussaed, Eman, Elhag, Imad, AlFiaar, Abdullah“…VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1465801416161912…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23963“…BACKGROUND: Combination of the inhaled long-acting muscarinic antagonist umeclidinium (UMEC; GSK573719) with the long-acting β(2)-agonist vilanterol (VI) is an approved maintenance treatment for COPD in the US and EU. We compared the efficacy and safety of UMEC/VI with placebo in patients with COPD of Asian ancestry. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23964“…This would allow an analytical sensitivity (AS) of 0.0001 fibres per millilitre (f ml(−1)) to be achieved, which is 1000 times lower than the EU and UK workplace control limit of 0.1 f ml(−1). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23965por Gross, Annette S., Goldfrad, Caroline, Hozawa, Soichiro, James, Mark H., Clifton, Christine S., Sugiyama, Yutaro, Jacques, Loretta“…BACKGROUND: Fluticasone furoate (FF)/vilanterol (VI) is a once daily (OD) inhaled corticosteroid/long-acting β(2)-agonist combination asthma therapy approved in Japan and the EU. FF/VI efficacy and safety data from asthma studies including patients in East Asia were evaluated to assess ethnic sensitivity. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23966por Docherty, Annemarie B, O’Donnell, Rob, Brunskill, Susan, Trivella, Marialena, Doree, Carolyn, Holst, Lars, Parker, Martyn, Gregersen, Merete, Pinheiro de Almeida, Juliano, Walsh, Timothy S, Stanworth, Simon J“…We searched (to 2 November 2015) CENTRAL, Medline, Embase, CINAHL, PubMed, LILACS, NHSBT Transfusion Evidence Library, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ISRCTN Register, and EU Clinical Trials Register. Authors were contacted for data whenever possible. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23967por Lampl, Christian, Thomas, Hallie, Tassorelli, Cristina, Katsarava, Zaza, Laínez, Jose Miguel, Lantéri-Minet, Michel, Rastenyte, Daiva, Ruiz de la Torre, Elena, Stovner, Lars Jacob, Andrée, Colette, Steiner, Timothy J.“…METHODS: Eurolight was a cross-sectional survey sampling from the adult populations (18–65 years) of 10 EU countries. We used data from six. The questionnaire included headache-diagnostic questions based on ICHD-II, the Headache-Attributed Lost Time (HALT) questionnaire, and HADS for depression and anxiety. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23968por Garcia-Alvarez, Alicia, Mila-Villarroel, Raimon, Ribas-Barba, Lourdes, Egan, Bernadette, Badea, Mihaela, Maggi, Franco M., Salmenhaara, Maija, Restani, Patrizia, Serra-Majem, Lluis“…Although limited by a small sample size, our study represents a first attempt at analysing such data in six EU countries. Our findings should encourage the conduction of further studies on this topic, long-term and large sample-sized studies, ideally conducted in the general population.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23969por Burke, Carol A., Dekker, Evelien, Samadder, N. Jewel, Stoffel, Elena, Cohen, Alfred“…TRIAL REGISTRATION: This trial is registered at ClinicalTrials.gov (NCT01483144; November 21, 2011) and the EU Clinical Trials Register(EudraCT 2012-000427-41; May 15, 2014). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23970por Forde, Natalie J., Kanaan, Ahmad S., Widomska, Joanna, Padmanabhuni, Shanmukha S., Nespoli, Ester, Alexander, John, Rodriguez Arranz, Juan I., Fan, Siyan, Houssari, Rayan, Nawaz, Muhammad S., Rizzo, Francesca, Pagliaroli, Luca, Zilhäo, Nuno R., Aranyi, Tamas, Barta, Csaba, Boeckers, Tobias M., Boomsma, Dorret I., Buisman, Wim R., Buitelaar, Jan K., Cath, Danielle, Dietrich, Andrea, Driessen, Nicole, Drineas, Petros, Dunlap, Michelle, Gerasch, Sarah, Glennon, Jeffrey, Hengerer, Bastian, van den Heuvel, Odile A., Jespersgaard, Cathrine, Möller, Harald E., Müller-Vahl, Kirsten R., Openneer, Thaïra J. C., Poelmans, Geert, Pouwels, Petra J. W., Scharf, Jeremiah M., Stefansson, Hreinn, Tümer, Zeynep, Veltman, Dick J., van der Werf, Ysbrand D., Hoekstra, Pieter J., Ludolph, Andrea, Paschou, Peristera“…TS-EUROTRAIN (FP7-PEOPLE-2012-ITN, Grant Agr.No. 316978) is a Marie Curie Initial Training Network (http://ts-eurotrain.eu) that aims to elucidate the complex etiology of the onset and clinical course of GTS, investigate the neurobiological underpinnings of GTS and related disorders, translate research findings into clinical applications, and establish a pan-European infrastructure for the study of GTS. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23971por Propper, David, Jones, Keith, Anthoney, D. Alan, Mansoor, Wasat, Ford, Daniel, Eatock, Martin, Agarwal, Roshan, Inatani, Michiyasu, Saito, Tomohisa, Abe, Masaichi, Evans, T. R. Jeffry“…CONCLUSIONS: This study of TP300 showed good drug tolerability but it failed to demonstrate sufficient efficacy as measured by radiological response. TRIAL REGISTRATION: EU-CTR 2009-012097-12 2009-09-03…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23972por Mazzette, Rina, Piras, Francesca, Agus, Vanessa, Porcheddu, Gabriella, Fois, Giuseppe, Consolati, Simonetta Gianna“…Six agritourisms outbuilding slaughterhouses – EU-approved – were investigated. General and hygiene requirements of outbuilding slaughterhouses and animal welfare indicators of 68 piglets and 5 finishing pigs were evaluated by mean of a checklist. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23973“…TRIAL REGISTRATION: EWO-ISO-2014/1, EudraCT 2014-001863-11; Date of registration: 29 APR 2014; Detail information web link: https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001863-11/results ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1965-5) contains supplementary material, which is available to authorized users.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23974por Feil, Katharina, Adrion, Christine, Teufel, Julian, Bösch, Sylvia, Claassen, Jens, Giordano, Ilaria, Hengel, Holger, Jacobi, Heike, Klockgether, Thomas, Klopstock, Thomas, Nachbauer, Wolfgang, Schöls, Ludger, Stendel, Claudia, Uslar, Ellen, van de Warrenburg, Bart, Berger, Ingrid, Naumann, Ivonne, Bayer, Otmar, Müller, Hans-Helge, Mansmann, Ulrich, Strupp, Michael“…TRIAL REGISTRATION: The trial was prospectively registered at www.clinicaltrialsregister.eu (EudraCT no. 2015–000460–34) and at https://www.germanctr.de (DRKS-ID: DRKS00009733).…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23975“…BACKGROUND AND OBJECTIVE: Once-daily oral fingolimod is approved in the EU as escalation treatment for adult patients with highly active relapsing multiple sclerosis (MS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23976por Mroczkowska, Aneta, Żmudzki, Jacek, Marszałek, Natalia, Orczykowska-Kotyna, Monika, Komorowska, Iga, Nowak, Agnieszka, Grzesiak, Anna, Czyżewska-Dors, Ewelina, Dors, Arkadiusz, Pejsak, Zygmunt, Hryniewicz, Waleria, Wyszomirski, Tomasz, Empel, Joanna“…CONCLUSIONS: The prevalence of LA-MRSA-positive pig farms in Poland has increased considerably since 2008, when the first MRSA EU baseline survey was conducted in Europe. On Polish pig farms CC398 of the animal clade predominates, this being also reflected in the prevalence of CC398 nasal carriage in farmers and veterinarians. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23977por Botezat, Olga, van Leusen, Jan, Kravtsov, Victor Ch., Kögerler, Paul, Baca, Svetlana G.“…The {Fe(4)Ln(2)}-type compounds [Fe(4)Ln(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)]·2(EtOH), Ln = Dy (1a), Er (1b), Ho (1c); [Fe(4)Tb(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)] (1d); [Fe(4)Ln(2)(O(2)CCMe(3))(6)(N(3))(4)(Htea)(4)]·2(CH(2)Cl(2)), Ln = Dy (2a), Er (2b); [Fe(4)Ln(2)(O(2)CCMe(3))(4)(N(3))(6)(Htea)(4)]·2(EtOH)·2(CH(2)Cl(2)), Ln = Dy (3a), Er (3b) and the {Fe(18)M(6)}-type compounds [Fe(18)M(6)(O(2)CCHMe(2))(12)(Htea)(18)(tea)(6)(N(3))(6)]·n(solvent), M = Dy (4, 4a), Gd (5), Tb (6), Ho (7), Sm (8), Eu (9), and Y (10) form in ca. 20–40% yields in direct reaction of trinuclear Fe(III) pivalate or isobutyrate clusters, lanthanide/yttrium nitrates, and bridging triethanolamine (H(3)tea) and azide ligands in different solvents: EtOH for the smaller {Fe(4)Ln(2)} wheels and MeOH/MeCN or MeOH/EtOH for the larger {Fe(18)M(6)} wheels. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23978por Muntau, Ania C., Burlina, Alberto, Eyskens, François, Freisinger, Peter, De Laet, Corinne, Leuzzi, Vincenzo, Rutsch, Frank, Sivri, H. Serap, Vijay, Suresh, Bal, Milva Orquidea, Gramer, Gwendolyn, Pazdírková, Renata, Cleary, Maureen, Lotz-Havla, Amelie S., Munafo, Alain, Mould, Diane R., Moreau-Stucker, Flavie, Rogoff, Daniela“…Based on the SPARK trial results, sapropterin has received EU approval to treat patients <4 years with BH(4)-responsive phenylketonuria. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23979por Ball, Jane, Day, Tina, Murrells, Trevor, Dall’Ora, Chiara, Rafferty, Anne Marie, Griffiths, Peter, Maben, Jill“…METHODS: Data were collected from a questionnaire survey of nurses in a sample of English hospitals, conducted as part of the RN4CAST study, an EU 7(th) Framework funded study. The sample comprised 31 NHS acute hospital Trusts from 401 wards, in 46 acute hospital sites. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23980por Vigone, Barbara, Caronni, Monica, Severino, Adriana, Bellocchi, Chiara, Baldassarri, Anna Rita, Fraquelli, Mirella, Montanelli, Gaia, Santaniello, Alessandro, Beretta, Lorenzo“…In patients with mild to severe gastrointestinal problems, prucalopride may be effective in treating dismotility symptoms, increasing the number of complete bowel movements and improving bowel transit, reducing reflux disease and bloating. TRIAL REGISTRATION: EU Clinical Trial Registry, EudraCT2012-005348-92. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto